Comparison of cardiac troponin I with CK-MB in the diagnosis of myocardial injury in children
Zheng Xiao-qin
Abstract
Zheng Xiao-qin
Abstract
Objective To determine the impacts of various pathological changes on serum cardiac troponin I (cTnI) levels and creatine kinase MB isoenzyme (CK-MB) activity and to compare the diagnostic values of cTnI with that of CK-MB. Methods Serum cTnI levels and CK-MB activity were measured in four groups of children. Group A included 54 healthy children as control. Group B included 53 pediatric patients without cardiac diseases. Group C included 12 pediatric patients with stable congenital heart diseases. Group D included 14 pediatric patients with acute myocarditis. Results The cTnI levels were all less than 0.25 μg/mL in group A and there were no significant differences among the subgroups of different ages. CK-MB was increased in one patient (1.9%). cTnI did not differ significantly among groups A, B, and C. One patient (1.9%) had elevated cTnI and nine patients (16.9%) had higher CK-MB in group B. No increase in cTnI occurred in group C whereas CK-MB was elevated in one patient (8.3%). cTnI in group D was increased in 11 patients and its mean value was markedly higher than that in group A (P 0.01). Conclusion cTnI can be used to diagnose myocardial injury in children with a high specificity and sensitivity. No elevation in cTnI occurred in the children who have no cardiovascular diseases. CK-MB activity, however, can be affected by other disorders besides cardiovascular diseases.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To determine the impacts of various pathological changes on serum cardiac troponin I (cTnI) levels and creatine kinase MB isoenzyme (CK-MB) activity and to compare the diagnostic values of cTnI with that of CK-MB. Methods Serum cTnI levels and CK-MB activity were measured in four groups of children. Group A included 54 healthy children as control. Group B included 53 pediatric patients without cardiac diseases. Group C included 12 pediatric patients with stable congenital heart diseases. Group D included 14 pediatric patients with acute myocarditis. Results The cTnI levels were all less than 0.25 μg/mL in group A and there were no significant differences among the subgroups of different ages. CK-MB was increased in one patient (1.9%). cTnI did not differ significantly among groups A, B, and C. One patient (1.9%) had elevated cTnI and nine patients (16.9%) had higher CK-MB in group B. No increase in cTnI occurred in group C whereas CK-MB was elevated in one patient (8.3%). cTnI in group D was increased in 11 patients and its mean value was markedly higher than that in group A (P 0.01). Conclusion cTnI can be used to diagnose myocardial injury in children with a high specificity and sensitivity. No elevation in cTnI occurred in the children who have no cardiovascular diseases. CK-MB activity, however, can be affected by other disorders besides cardiovascular diseases.
Key concepts: Troponin I, Medicine, Internal medicine, Cardiology, Creatine kinase, Troponin, Myocarditis, Pathological